Shares in Third Wave Technologies declined 10 percent for the five-day trading period ended Tuesday. The firm filed a countersuit against Digene last week in a patent dispute over HPV molecular diagnostics (see related article).
Bruker BioSciences led the five firms in the BCW Index that gained ground for the week, rising 7.2 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.